Naz News, Gappers and FLE's

[sludgehound]

GALT down hard on drug story 8-K -37%

C 14.54 pre -33% 8-k drug story.

08:48 AM EDT, 07/29/2014 (MT Newswires) --
Price: 9.02, Change: -5.52, Percent Change: -37.96

This used to be a trader fave on long run up. 22M O/S had 1 R/S for 1-6 3/23/12 where run began from 2 lows to high 18.
SeekingAlpha did a job on them.
* 8-K from Galectin Shows GR-MD-02 Was Safe, Well Tolerated in Recent Trial, Primary Endpoints in Cohort 2 Were Met

* UPDATE: Galectin Shares Fall 32% Premarket Following Release of 8-K

http://www.sec.gov/Archives/edgar/data/1133416/000119312514283595/d76198...
From slide 6: "While the overall impression of biomarker analysis suggests an effect of the drug, there are differences in biomarker changes depending on the timing of blood sampling with respect to drug dose."
From slide 13: "There is an indication of an effect in both cohorts, while not statistically significant."
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.